Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder
Key facts
- Who runs it
- Stanford University
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 17 Dec 2025
- Expected to end
- 30 Jun 2030
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active
- Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham
- Record updated
- 15 May 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age 18-75
- Current DSM-5 diagnosis of moderate to severe AUD (\≥4 diagnostic symptoms)
- Ability to obtain a Motor Threshold (MT) will be determined during the screening process
- Has an adequately stable condition and environment to enable attendance at scheduled clinic visits
- Able to read, understand and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments
- If on a medication regimen for comorbid symptoms, that regimen will be stable for the duration of the study and patient will be willing to remain on this regimen during the treatment phase
- Fluency in English
Who cannot take part
- Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk
- Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in the body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/objected in the head and body within 30 cm of the treatment coil
- General medical condition, disease or neurological disorder that interferes with the assessments or participation
- Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder
- Taking benzodiazepine or neuroleptic medications, or any medication known to alter seizure threshold
- Acute or unstable chronic illness
- Current or lifetime history of bipolar disorder or psychosis
- Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen
- A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study
- Severe impediment to vision, hearing and/or hand movement, likely to interfere with the ability to follow study protocols
- Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in United States.
- VA Palo Alto Health Care SystemPalo Alto, United StatesContact: Eileen G Fischer, BSTaking people
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.
The 2 groups in the trial
- Active dTMSTreatment being tested
Participants will receive 30 sessions of active-dTMS to the dACC/mPFC with the H7 coil, administered 3 times per day over 10 consecutive business days. Each treatment visit will last approximately 30 minutes in total.
Treatment: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active
- Sham dTMSSham treatment, for comparison
Participants will receive 30 sham dTMS sessions, administered 3 times per day over 10 consecutive business days. Each treatment visit will last approximately 30 minutes in total.
Treatment: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder
- Criteria questions
- Built from NCT06949423, who can take part
- Record updated
- 15 May 2026